The FDA usually follows the recommendations of its advisory panels.
Advisory panel members have been cleared of potential conflicts related to the meeting topic. Occasionally, a panelist is given a waiver, but no waivers were given at this meeting.
News
FDA Panel Backs Cobas HPV Test as Primary Screening Tool
Publish date: March 13, 2014
Author and Disclosure Information
Elizabeth Mechcatie, Family Practice News Digital Network
AT AN FDA ADVISORY COMMITTEE MEETING